146 related articles for article (PubMed ID: 38661480)
1. Quality by Design Considerations for Drop-on-Demand Point-of-Care Pharmaceutical Manufacturing of Precision Medicine.
Forbes TP; Gillen JG; Feeney W; Ho J
Mol Pharm; 2024 Jul; 21(7):3268-3280. PubMed ID: 38661480
[TBL] [Abstract][Full Text] [Related]
2. Drop-on-demand printing of personalised orodispersible films fabricated by precision micro-dispensing.
Tam CH; Alexander M; Belton P; Qi S
Int J Pharm; 2021 Dec; 610():121279. PubMed ID: 34774697
[TBL] [Abstract][Full Text] [Related]
3. Therapy for the individual: Towards patient integration into the manufacturing and provision of pharmaceuticals.
Govender R; Abrahmsén-Alami S; Larsson A; Folestad S
Eur J Pharm Biopharm; 2020 Apr; 149():58-76. PubMed ID: 31982577
[TBL] [Abstract][Full Text] [Related]
4. Printing medicines as orodispersible dosage forms: Effect of substrate on the printed micro-structure.
Planchette C; Pichler H; Wimmer-Teubenbacher M; Gruber M; Gruber-Woelfler H; Mohr S; Tetyczka C; Hsiao WK; Paudel A; Roblegg E; Khinast J
Int J Pharm; 2016 Jul; 509(1-2):518-527. PubMed ID: 26541301
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical Additive Manufacturing: a Novel Tool for Complex and Personalized Drug Delivery Systems.
Zhang J; Vo AQ; Feng X; Bandari S; Repka MA
AAPS PharmSciTech; 2018 Nov; 19(8):3388-3402. PubMed ID: 29943281
[TBL] [Abstract][Full Text] [Related]
6. 3D-Printed Drugs for Children-Are We Ready Yet?
Preis M; Öblom H
AAPS PharmSciTech; 2017 Feb; 18(2):303-308. PubMed ID: 28078628
[TBL] [Abstract][Full Text] [Related]
7. Re-Envisioning Pharmaceutical Manufacturing: Increasing Agility for Global Patient Access.
Algorri M; Abernathy MJ; Cauchon NS; Christian TR; Lamm CF; Moore CMV
J Pharm Sci; 2022 Mar; 111(3):593-607. PubMed ID: 34478754
[TBL] [Abstract][Full Text] [Related]
8. Managing API raw material variability during continuous twin-screw wet granulation.
Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Vervaet C; De Beer T
Int J Pharm; 2019 Apr; 561():265-273. PubMed ID: 30851387
[TBL] [Abstract][Full Text] [Related]
9. Developing a Modular Continuous Drug Product Manufacturing System with Real Time Quality Assurance for Producing Pharmaceutical Mini-Tablets.
Sundarkumar V; Wang W; Mills M; Oh SW; Nagy Z; Reklaitis G
J Pharm Sci; 2024 Apr; 113(4):937-947. PubMed ID: 37788791
[TBL] [Abstract][Full Text] [Related]
10. Application of 3D printing in early phase development of pharmaceutical solid dosage forms.
Milliken RL; Quinten T; Andersen SK; Lamprou DA
Int J Pharm; 2024 Mar; 653():123902. PubMed ID: 38360287
[TBL] [Abstract][Full Text] [Related]
11. Analysis of potential genotoxic impurities in rabeprazole active pharmaceutical ingredient via Liquid Chromatography-tandem Mass Spectrometry, following quality-by-design principles for method development.
Iliou K; Malenović A; Loukas YL; Dotsikas Y
J Pharm Biomed Anal; 2018 Feb; 149():410-418. PubMed ID: 29154196
[TBL] [Abstract][Full Text] [Related]
12. Dropwise additive manufacturing of pharmaceutical products for amorphous and self emulsifying drug delivery systems.
Içten E; Purohit HS; Wallace C; Giridhar A; Taylor LS; Nagy ZK; Reklaitis GV
Int J Pharm; 2017 May; 524(1-2):424-432. PubMed ID: 28380390
[TBL] [Abstract][Full Text] [Related]
13. Small-Scale Continuous Drug Product Manufacturing using Dropwise Additive Manufacturing and Three Phase Settling for Integration with Upstream Drug Substance Production.
Sundarkumar V; Nagy ZK; Reklaitis GV
J Pharm Sci; 2022 Aug; 111(8):2330-2340. PubMed ID: 35341723
[TBL] [Abstract][Full Text] [Related]
14. Manufacturing pharmaceutical mini-tablets for pediatric patients using drop-on-demand printing.
Sundarkumar V; Wang W; Nagy Z; Reklaitis G
Int J Pharm; 2023 Sep; 644():123355. PubMed ID: 37647980
[TBL] [Abstract][Full Text] [Related]
15. Managing API raw material variability in a continuous manufacturing line - Prediction of process robustness.
Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Vervaet C; De Beer T
Int J Pharm; 2019 Oct; 569():118525. PubMed ID: 31319146
[TBL] [Abstract][Full Text] [Related]
16. Inkjet printing of drug substances and use of porous substrates-towards individualized dosing.
Sandler N; Määttänen A; Ihalainen P; Kronberg L; Meierjohann A; Viitala T; Peltonen J
J Pharm Sci; 2011 Aug; 100(8):3386-3395. PubMed ID: 21360709
[TBL] [Abstract][Full Text] [Related]
17. Binder jetting 3D printing in fabricating pharmaceutical solid products for precision medicine.
Wang Y; Genina N; Müllertz A; Rantanen J
Basic Clin Pharmacol Toxicol; 2024 Mar; 134(3):325-332. PubMed ID: 38105694
[TBL] [Abstract][Full Text] [Related]
18. Drop-on-Demand System for Manufacturing of Melt-based Solid Oral Dosage: Effect of Critical Process Parameters on Product Quality.
Içten E; Giridhar A; Nagy ZK; Reklaitis GV
AAPS PharmSciTech; 2016 Apr; 17(2):284-93. PubMed ID: 26082005
[TBL] [Abstract][Full Text] [Related]
19. Additive Manufacturing with 3D Printing: Progress from Bench to Bedside.
Rahman Z; Barakh Ali SF; Ozkan T; Charoo NA; Reddy IK; Khan MA
AAPS J; 2018 Sep; 20(6):101. PubMed ID: 30209693
[TBL] [Abstract][Full Text] [Related]
20. The use of near-infrared as process analytical technology (PAT) during 3D printing tablets at the point-of-care.
Yang TL; Szewc J; Zhong L; Leonova A; Giebułtowicz J; Habashy R; Isreb A; Alhnan MA
Int J Pharm; 2023 Jul; 642():123073. PubMed ID: 37230372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
